The effect of age on efficacy and safety outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase III, randomized, placebo-controlled maintenance study in patients with recurrent ovarian carcinoma Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C. A.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; Holloway, R. W.; Amenedo Gancedo, M.; Fong, P. C. C.; Goh, J. C.; Backes, F. J.; Banerjee, S.; Goble, S.; Cameron, T.; Coleman, R. L.

authors

Publication Date

  • June 1, 2019

webpage

published in

category

start page

  • 4

end page

  • 5

volume

  • 154